Compare PACK & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PACK | TOI |
|---|---|---|
| Founded | 1972 | 2007 |
| Country | United States | United States |
| Employees | N/A | 641 |
| Industry | Containers/Packaging | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 653.6M | 579.9M |
| IPO Year | 2017 | N/A |
| Metric | PACK | TOI |
|---|---|---|
| Price | $6.89 | $5.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.50 | ★ $6.67 |
| AVG Volume (30 Days) | 574.7K | ★ 2.0M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $395,000,000.00 | N/A |
| Revenue This Year | $9.29 | $30.15 |
| Revenue Next Year | $8.35 | $25.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $3.22 | $2.32 |
| 52 Week High | $7.81 | $6.11 |
| Indicator | PACK | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 52.25 | 65.47 |
| Support Level | $6.59 | $3.24 |
| Resistance Level | $7.16 | N/A |
| Average True Range (ATR) | 0.35 | 0.37 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 46.85 | 83.47 |
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.